关注
Friederike M. Dannheim
Friederike M. Dannheim
Senior scientist, AstraZeneca
在 astrazeneca.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Site-selective modification strategies in antibody–drug conjugates
SJ Walsh, JD Bargh, FM Dannheim, AR Hanby, H Seki, AJ Counsell, X Ou, ...
Chemical Society Reviews 50 (2), 1305-1353, 2021
2782021
Synthesis of anti-1,3 Amino Alcohol Motifs via Pd(II)/SOX Catalysis with the Capacity for Stereodivergence
R Ma, J Young, R Promontorio, FM Dannheim, CC Pattillo, MC White
Journal of the American Chemical Society 141 (24), 9468-9473, 2019
312019
An automated computational approach to kinetic model discrimination and parameter estimation
CJ Taylor, H Seki, FM Dannheim, MJ Willis, G Clemens, BA Taylor, ...
Reaction Chemistry & Engineering 6 (8), 1404-1411, 2021
192021
All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading
FM Dannheim, SJ Walsh, CT Orozco, AH Hansen, JD Bargh, SE Jackson, ...
Chemical Science 13 (30), 8781-8790, 2022
172022
Divinylpyrimidine reagents generate antibody–drug conjugates with excellent in vivo efficacy and tolerability
SJ Walsh, S Omarjee, FM Dannheim, DL Couturier, D Bexheti, L Mendil, ...
Chemical Communications 58 (12), 1962-1965, 2022
132022
Development of a Novel Bioconjugation Platform for the Generation of Homogenous Antibody-Drug Conjugates
F Dannheim
12021
系统目前无法执行此操作,请稍后再试。
文章 1–6